antithrombin III

Preferred Label : antithrombin III;

MeSH definition : A plasma alpha 2 glycoprotein that accounts for the major antithrombin activity of normal plasma and also inhibits several other enzymes. It is a member of the serpin superfamily.;

MeSH synonym : heparin co-factor i; heparin co factor i; cofactor i, heparin; heparin cofactor i; Serpin C1;

CISMeF synonym : antithrombin ii; factor xa inhibitor; 52014-67-2; antithrombin iii, human plasma; antithrombin; antithrombin baxter brand; baxter brand of antithrombin; antithrombin bayer brand; antithrombin grifols brand; antithrombin pharmacia brand; aventis behring brand of antithrombin III; bayer brand of antithrombin; grifols brand of antithrombin; pharmacia brand of antithrombin;

CISMeF acronym : AT III;

MeSH hyponym : atenativ; antithrombin III-Alpha; kybernin; thrombate III; Antithrombin III Alpha; Antithrombin IIIAlpha;

Registry Number MeSH : 9000-94-6;

Codes EINECS : 232-568-2;

Is substance : O;

UNII : T0LTO7L82X;

Details

Origin ID

D000990;

UMLS CUI

C0003438;

ATC code(s)
- antithrombin III [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analogs and derivatives [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- biosynthesis [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- drug effects [MeSH Qualifier]
- economics [MeSH Qualifier]
- genetics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- physiology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- ultrastructure [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- Antithrombin (substance) [Inactive SNOMED CT concept]
- Antithrombin Antigen Measurement [NCIt concept]
- Antithrombin III [ICD-11 Extension code]
- Coagulation factor Xa inhibitor (disposition) [SNOMED CT concept]
- Human antithrombin III (substance) [SNOMED CT concept]
- Serpin peptidase inhibitor, clade C (antithrombin), member 1 [OMIM gene]
- antithrombin i [SNOMED Notion]
- antithrombin ii [SNOMED Notion]
- heparin cofactor ii [SNOMED Notion]
- heparin cofactor, nos [SNOMED Notion]
- serpin family C member 1 [ORDO Gene]
- serpin family C member 1 [HGNC gene]
CISMeF manual mappings
- Antithrombin III (substance) [SNOMED CT concept]
Currated CISMeF NLP mapping
- Antithrombin [LOINC component]
- Antithrombin-III [NCIt concept]
- antithrombin [Substance BNPC]
- antithrombin III [Blood Transfusion thesaurus concept]
- antithrombin iii [SNOMED Notion]
- heparin cofactor i [SNOMED Notion]
False automatic mappings
- Roman numeral III (qualifier value) [SNOMED CT concept]
- Third [NCIt concept]
Indexing information
- epicatechin sulfate [MeSH Supplementary Concept]
- tosyl-glycyl-prolyl-arginyl-4-methylcoumaryl-7-amide [MeSH Supplementary Concept]
Manual BTNT mappings - CISMeF
- Human antithrombin III (substance) [SNOMED CT concept]
Pharmacological action(s)
- antithrombins [MeSH Descriptor]
Record concept(s)
- antithrombin III [MeSH concept]
- antithrombin III-Alpha [MeSH concept]
- atenativ [MeSH concept]
- kybernin [MeSH concept]
- thrombate III [MeSH concept]
Related MeSH Supplementary Concept(s)
- PB 145 [MeSH Supplementary Concept]
- SERPINC1 protein, human [MeSH Supplementary Concept]
- antithrombin (342-347) [MeSH Supplementary Concept]
- antithrombin III Arg197STOP [MeSH Supplementary Concept]
- antithrombin III Padua(2) [MeSH Supplementary Concept]
- antithrombin III aalborg [MeSH Supplementary Concept]
- antithrombin III alger [MeSH Supplementary Concept]
- antithrombin III avranches [MeSH Supplementary Concept]
- antithrombin III barcelona [MeSH Supplementary Concept]
- antithrombin III barcelona 2 [MeSH Supplementary Concept]
- antithrombin III basel [MeSH Supplementary Concept]
- antithrombin III budapest 2 [MeSH Supplementary Concept]
- antithrombin III cambridge [MeSH Supplementary Concept]
- antithrombin III charleville [MeSH Supplementary Concept]
- antithrombin III clichy [MeSH Supplementary Concept]
- antithrombin III denver [MeSH Supplementary Concept]
- antithrombin III dublin [MeSH Supplementary Concept]
- antithrombin III dublin 2 [MeSH Supplementary Concept]
- antithrombin III fontainebleau [MeSH Supplementary Concept]
- antithrombin III franconville [MeSH Supplementary Concept]
- antithrombin III geneva [MeSH Supplementary Concept]
- antithrombin III glasgow [MeSH Supplementary Concept]
- antithrombin III hamilton [MeSH Supplementary Concept]
- antithrombin III kumamoto [MeSH Supplementary Concept]
- antithrombin III kyoto [MeSH Supplementary Concept]
- antithrombin III milano [MeSH Supplementary Concept]
- antithrombin III nagasaki [MeSH Supplementary Concept]
- antithrombin III northwick park [MeSH Supplementary Concept]
- antithrombin III padua [MeSH Supplementary Concept]
- antithrombin III paris [MeSH Supplementary Concept]
- antithrombin III roma [MeSH Supplementary Concept]
- antithrombin III rouen [MeSH Supplementary Concept]
- antithrombin III sheffield [MeSH Supplementary Concept]
- antithrombin III stockholm [MeSH Supplementary Concept]
- antithrombin III sudbury [MeSH Supplementary Concept]
- antithrombin III tours [MeSH Supplementary Concept]
- antithrombin III toyama [MeSH Supplementary Concept]
- antithrombin III utah [MeSH Supplementary Concept]
- antithrombin III vicenza [MeSH Supplementary Concept]
- antithrombin III-protease complex [MeSH Supplementary Concept]
- antithrombin III-trypsin complex [MeSH Supplementary Concept]
- antithrombin cambridge II [MeSH Supplementary Concept]
- factor IX-antithrombin III complex [MeSH Supplementary Concept]
Related MeSH term(s)
- antithrombin iii deficiency [MeSH Descriptor]
See also (suggested by CISMeF)
- anticoagulants [MeSH Descriptor]
See also inter- (CISMeF)
- Antithrombin Activity Measurement [NCIt concept]
- Antithrombin III [MedDRA Preferred Term]
- Heparin cofactor (substance) [SNOMED CT concept]
- Product containing antithrombin III (medicinal product) [SNOMED CT concept]
Semantic type(s)
- Amino Acid, Peptide, or Protein [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Antithrombin [LOINC component]
- Antithrombin III (substance) [SNOMED CT concept]
- Product containing antithrombin III (medicinal product) [SNOMED CT concept]
- antithrombin III [ATC Code]
- antithrombin ii [SNOMED Notion]
- antithrombin iii [SNOMED Notion]
- heparin cofactor i [SNOMED Notion]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients